Over 400 attendees representing global pharmaceutical organizations, leading biotech companies and internationally renowned academic institutions
A look at the future of drug discovery in new modalities in biotherapeutics, proteins, cell and genetic based discovery.
The latest updates on the integration of screening approaches in phenotypic and genomics based discovery, Organ on the chip and 3D modelling, RNA as novel drug targets.
Insights into drug discovery strategies & next generation therapeutics, empowering drug discovery with chemical biology, target validation, drug profiling and protein degradation technologies.
Come talk with Dotmatics Staff at Booth 23.